AIとがん研究 ── 肝臓がん ── 2026-11-13
肝臓がん 2 本。筆頭: Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio
肝臓がんの治療・治験とAI
- Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio抄録(全訳)掲載誌の IF 相当:3.5(OpenAlex の直近 2 年の平均被引用数・2026-11-11 時点の値、2026-11-12 に取得。正式な IF(Clarivate)ではない)書誌:[No authors listed]. Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio. Gut. [Epub ahead of print]. doi:.確認の範囲:抄録のみ確認
- Machine learning model using contrast-enhanced CT for predicting overall survival in unresectable hepatocellular carcinoma treated with TACE plus targeted and immunotherapy: a multicenter study抄録(全訳)掲載誌の IF 相当:5.9(OpenAlex の直近 2 年の平均被引用数・2026-11-04 時点の値、2026-11-05 に取得。正式な IF(Clarivate)ではない)書誌:Ning S, Chen Y, Feng B, Sun Z, Qu Q, Lv Y, et al. Machine learning model using contrast-enhanced CT for predicting overall survival in unresectable hepatocellular carcinoma treated with TACE plus targeted and immunotherapy: a multicenter study. Sci Rep. 2026 Nov 10;16(1):37437. doi:10.1038/s41598-026-64608-3.確認の範囲:抄録のみ確認